This is the company’s first clearance in its Lucent 3D line, according to an April 20 news release. The 3D-printed implant comprises a strut-and-lattice structure with a bone graft chamber access lid. The FDA clearance allows the company to stand out in the 3D-printed interbody market.
“Lucent 3D’s novel design is meant to address the challenges surgeons have shared with us of other 3D-printed interbody devices — subsidence and the amount of bone graft material available for fusion,” President and CEO Jason Blain said.
More articles on devices:
Former Laser Spine Institute leader named chief of surgery at Florida practice
Late-week spine surgeries linked to longer hospital stays, study finds
Spine spinoff, partial knee robot & more: 6 key Zimmer Biomet developments
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.